On this week’s episode, Chris Garabedian, Brian Skorney, and Sam Fazeli open with optimism about the biotech market, predicting an upcoming acceleration in IPO activity. In deals and financing news, the co-hosts discussed Summit Therapeutics’ $500 million raise, with more than half coming from insiders, and continued momentum in M&A, including Alkermes’ $2.1 billion acquisition of Avadel for its narcolepsy drug. The group also highlighted Takeda’s $1.2 billion oncology deal with Innovent

Send us a text Episode 38 Diverticulitis Shoot me any comments or questions @Rotation2ptoh on X Intro Music: KI Instrumental (Rock Celtic) by Lyrium-2025 Outro Music: Breaking Free by Alex Grohl Courtesy of Pixabay under Creative Commons non-commercial use. Produced by: Todd Fredricks DO MSS Edited by: Todd Fredricks DO MSS Answers for Episode 37 Cholelithiasis Question 1: Pathophysiology and Risk Factors A 45-year-old woman presents with intermittent right upper quadrant pain aft...

🎧 ÉPISODE 13 – PODCAST DÉCOUVERTE DE LA PHYSIOLOGIE 📚 Thème 5 : La ventilation – Aspects mécaniques de la ventilation pulmonaireAuteur : Yves Muller – Professeur Agrégé de classe exceptionnelle – Docteur en Neurosciences – Université de Montpellier – Département d’Enseignement et de Recherche : Biologie et Mécanismes du Vivant📺 Version vidéo disponible ici : https://youtu.be/r8AWY6GVByo⏱️ Sommaire de l’épisode 13 : 0:00 Introduction1:58 Organisation fonctionnelle du système respiratoire7:58

Pharma’s Top Management Digital Playbook: Navigating Digital Volatility In this episode of Center of Excellence – Pharma 4.0, we explore how top pharmaceutical executives are steering their organizations through an era of digital volatility. The conversation unpacks how leadership vision, cultural transformation, and technology integration are reshaping pharma’s competitive edge in a rapidly evolving landscape. From AI-driven decision-making to digital governance, cybersecurity, and quantum

סיפורי הכחדתם של ארבעה מיני עופות ייחודיים, על ידי בני אדם לאורך מאות השנים האחרונות00:00:00 פתיח 00:01:37 מואה 00:06:33 דודו 00:10:48 יונה נודדת 00:15:06 תוכון קרוליינה *מקורות להרחבה* מאמר על הכחדת המואה מאמר על הכחדת המואה בידי אוכלוסיה אנושית מצומצמת מאוד מאמר על הסביבה הטבעית של הדודו מאמר על הכחדת היונה הנודדת מאמר על הכחדת תוכון קרוליינה מוזמנים ליצור קשר במייל evolutionpodcast613@gmail.com

Welcome to The BiohubJoy Clark, Chief People Officer at Worldwide Clinical Trials, joins The BioHub Podcast to talk about building belonging, leading with purpose, and driving health equity in clinical research. Joy shares her journey from high-growth tech to the CRO world, how Worldwide has cultivated a culture that’s 73% women, and why human-centered leadership matters more than ever.

科研喵使用ai读文献，祝你效率百倍，访问labcat.com.cn下载。今天我们要介绍发表在Neurology(影响因子7.7)上的重要研究"Retinal Microvascular Correlates of Cerebral Small Vessel Disease in Older Age"。这项突破性研究发现，通过简单的视网膜检查可以预测老年人脑小血管病！研究显示，视网膜血管的几何特征与脑部MRI显示的小血管病变显著相关，特别是较低的小动脉分形维度和较大的静脉迂曲度。更令人惊讶的是，孟德尔随机化分析表明这种关联可能存在因果关系。这意味着未来医生可能只需通过眼底检查就能评估患者的大脑血管健康，为早期干预提供宝贵窗口，改变脑小血管病的筛查和监测方式。

Sylvain Berthelot welcomes Dr. Marek Wasiluk, CEO of ClinMark. With a career that spans from CRA to leading a global CRO, Marek brings a unique perspective on how clinical research organizations can embrace innovation while safeguarding trial quality.Together, they explore the fine balance between adopting new technologies and managing operational risk. Marek shares how his background in medicine, quality assurance, and clinical operations shapes his approach to implementing digital solutions that

In this episode, hosts Dom and John welcome Jason Hannah, Director of Marketing at KCAS Bio, to discuss the company’s strategy for navigating the 2025 global conference season. With major events like AAPS PharmSci 360 in the U.S. and the European Bioanalysis Forum (EBF) in Barcelona on the horizon, Jason explains how KCAS approaches each with a structured, three-phase plan: pre-show planning, on-site activation, and post-show follow-up. He highlights the differences between large, trade show–...

QUINTO DIA: DESPERTE SEU GIGANTE INTERIOR SETE DIAS PARA MOLDAR SUA VIDA

We just wrapped an incredible week at the American Society of Human Genetics (ASHG) 2025 Annual Meeting in the historic Boston, Massachusetts! This year’s gathering brought together thousands of geneticists, clinicians, and innovators to share discoveries that are reshaping the field. In this episode of DNA Today, host Kira Dineen takes you inside the conference experience, from lively poster sessions and thought-provoking sessions to spontaneous hallway conversations that sparked new ideas. You’ll

QUINTO DIA: DESPERTE SEU GIGANTE INTERIOR SETE DIAS PARA MOLDAR SUA VIDA

We talk with Dr. John Gridley, a postdoctoral fellow in the Vaccinology Training Program at Emory University, GA, who uses a hepatitis C virus-related rodent hepacivirus model to identify correlates of protective immunity for HCV and the role of inducible Hepatic-Associated Lymphoid Tissue (iHALT) in the induction of this immune response.

Dr Donald Lyall narrates his blog written for Dementia Researcher. In this guest blog, Donald draws lessons from legendary F1 designer Adrian Newey and the Race Against Dementia summit. Reflecting on Newey’s philosophy of learning from failure, teamwork, data integrity, and time for focused thought, Lyall shows how these principles can inform dementia research. By connecting motorsport precision with scientific collaboration, he highlights how structured creativity and belief in the

A behind-the-scenes look at what it takes to deliver quality at scale—people, processes, and lessons learned from 1000 studies.

W tym odcinku analizujemy rosnący rynek wyrobów medycznych w Meksyku, który do 2029 roku ma osiągnąć wartość 12,6 miliarda dolarów. Oma-wiamy kluczowe czynniki napędzające ten wzrost, takie jak starzejąca się populacja i rosnące zapotrzebowanie na importowane technologie. Przedstawiamy również organ regulacyjny COFEPRIS i wyjaśniamy dwie główne ścieżki rejestracji, które producenci muszą znać, aby skutecznie wejść na ten lukratywny rynek.- Dlaczego Meksyk jest jednym z najbardziej obiecujących

In dieser Folge spricht Denise mit Daniela Karl, der 1. Vorsitzenden vom BUVEBA, über die facettenreiche Welt der Studienkoordination und das Berufsbild. Sie beleuchten die spannende Vielfalt, die dieser Job mit sich bringt, sprechen offen über die Herausforderungen im Studienalltag und geben Einblicke, wie man eigentlich Studienkoordinator:in wird. Außerdem werfen sie einen Blick in die Zukunft, diskutieren über die Weiterbildungsmöglichkeiten und ihre Visionen für die Entwicklung des

Deze aflevering duikt in de bloeiende Mexicaanse markt voor medische hulpmiddelen, een markt die voor 90% afhankelijk is van import. We bespreken de belangrijkste regelgevende instantie, COFEPRIS, en de cruciale stappen voor buitenlandse fabrikanten om toegang te krijgen. We leggen de verschillende registratieroutes uit, inclusief de Standaard- en Equivalency-trajecten, en benadrukken de belangrijke regelgevende update die op 1 september 2025 van kracht wordt.- Waarom is de Mexicaanse markt voor